Synonyms: | |
Status: | Approved (2017) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N01BC01 |
UNII: | I5Y540LHVR |
InChI Key | ZPUCINDJVBIVPJ-LJISPDSOSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C17H21NO4 |
Molecular Weight | 303.36 |
AlogP | 1.87 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 55.84 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 22.0 |
Primary Target | |
---|---|
DAT |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 4-7244 | - | - | - | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 49000 | - | - | 20-63 | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Acetylcholine receptor
|
- | - | - | 61397-61400 | - | |
Membrane receptor
|
- | - | - | 61397-61400 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 66-15800 | - | 32-32000 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Substance Withdrawal Syndrome | 1 | D013375 | ClinicalTrials |
Hypersensitivity | 1 | D006967 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 50-36-2 |
ChEBI | 27958 |
ChEMBL | CHEMBL370805 |
DrugBank | DB00907 |
DrugCentral | 723 |
EPA CompTox | DTXSID2038443 |
FDA SRS | I5Y540LHVR |
Human Metabolome Database | HMDB0015043 |
Guide to Pharmacology | 2286 |
PDB | COC |
PubChem | 446220 |
SureChEMBL | SCHEMBL21930 |
ZINC | ZINC000003875336 |